Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Merck & Co. (MRK) shares rose 2.36% to $130.48, outperforming competitors like Johnson & Johnson, Pfizer, and Eli Lilly during a broader market decline where the S&P 500 fell 1.21%. This marks Merck's third consecutive day of gains, closing just below its 52-week high. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Merck & Co. Inc. (MRK) rose 2.36% to $130.48 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
This was the stock's third consecutive day of gains.
Merck & Co. Inc. closed 0.96% below its 52-week high of $131.74, which the company achieved on July 17th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Pfizer Inc. (PFE) rose 0.77% to $25.01, and Eli Lilly & Co. (LLY) rose 1.97% to $1,185.87.
Trading volume (8.5 M) remained 2.1 million below its 50-day average volume of 10.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1633ET